![](/wp-content/uploads/2022/08/August-10-2022-Blast-Cover.png)
$599
Xeris, Zealand, and MannKind Q2 ’22 Earnings Updates
Three cardiometabolic-related news items have been observed: Xeris Biopharma (press release), Zealand (press release; slides), and MannKind (press release; slides) hosted their Q2 ’22 earnings calls. Below, FENIX provides highlights and insights for the respective new items.